Great West Life Assurance CO Alnylam Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

A detailed history of Great West Life Assurance CO transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 68,713 shares of ALNY stock, worth $16.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
68,713
Previous 54,405 26.3%
Holding current value
$16.9 Million
Previous $13.2 Million 43.0%
% of portfolio
0.03%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$233.81 - $287.01 $3.35 Million - $4.11 Million
14,308 Added 26.3%
68,713 $18.9 Million
Q2 2024

Aug 12, 2024
BUY
$143.31 - $247.0 $983,106 - $1.69 Million
6,860 Added 14.43%
54,405 $13.2 Million
Q1 2024

May 13, 2024
BUY
$146.51 - $198.2 $264,304 - $357,552
1,804 Added 3.94%
47,545 $7.11 Million
Q4 2023

Feb 13, 2024
BUY
$151.41 - $196.57 $237,410 - $308,221
1,568 Added 3.55%
45,741 $8.7 Million
Q3 2023

Nov 14, 2023
SELL
$170.77 - $211.65 $130,468 - $161,700
-764 Reduced 1.7%
44,173 $7.82 Million
Q2 2023

Aug 10, 2023
BUY
$185.01 - $212.05 $356,699 - $408,832
1,928 Added 4.48%
44,937 $8.59 Million
Q1 2023

May 12, 2023
BUY
$182.66 - $235.53 $127,862 - $164,871
700 Added 1.65%
43,009 $8.63 Million
Q4 2022

Feb 10, 2023
SELL
$185.53 - $241.31 $57,143 - $74,323
-308 Reduced 0.72%
42,309 $10.1 Million
Q3 2022

Nov 01, 2022
BUY
$138.54 - $232.0 $5.9 Million - $9.89 Million
42,617 New
42,617 $8.51 Million
Q2 2022

Aug 09, 2022
SELL
$120.42 - $169.29 $1.49 Million - $2.1 Million
-12,385 Reduced 19.86%
49,984 $7.3 Million
Q1 2022

May 12, 2022
BUY
$127.18 - $173.91 $1.39 Million - $1.89 Million
10,892 Added 21.16%
62,369 $10.8 Million
Q4 2021

Feb 14, 2022
SELL
$159.56 - $209.29 $2.51 Million - $3.29 Million
-15,739 Reduced 23.42%
51,477 $8.71 Million
Q3 2021

Nov 15, 2021
SELL
$169.75 - $207.73 $619,927 - $758,629
-3,652 Reduced 5.15%
67,216 $12.8 Million
Q2 2021

Aug 11, 2021
SELL
$128.63 - $176.89 $1.12 Million - $1.54 Million
-8,697 Reduced 10.93%
70,868 $12 Million
Q1 2021

May 17, 2021
BUY
$126.83 - $175.69 $893,517 - $1.24 Million
7,045 Added 9.71%
79,565 $11.2 Million
Q4 2020

Feb 16, 2021
BUY
$122.97 - $147.0 $1.44 Million - $1.72 Million
11,676 Added 19.19%
72,520 $9.41 Million
Q3 2020

Nov 17, 2020
SELL
$121.19 - $165.49 $46.1 Million - $63 Million
-380,717 Reduced 86.22%
60,844 $8.86 Million
Q3 2020

Nov 13, 2020
BUY
$121.19 - $165.49 $46.1 Million - $62.9 Million
380,090 Added 618.32%
441,561 $64.3 Million
Q2 2020

Aug 17, 2020
BUY
$104.21 - $156.44 $1.6 Million - $2.41 Million
15,382 Added 33.37%
61,471 $9.06 Million
Q1 2020

May 14, 2020
BUY
$93.12 - $133.99 $8,194 - $11,791
88 Added 0.19%
46,089 $5.05 Million
Q4 2019

Feb 11, 2020
BUY
$74.51 - $124.23 $3.43 Million - $5.71 Million
46,001 New
46,001 $5.3 Million
Q3 2019

Oct 25, 2019
SELL
$70.9 - $87.82 $2.99 Million - $3.7 Million
-42,171 Closed
0 $0
Q2 2019

Jul 31, 2019
SELL
$65.86 - $92.79 $674,472 - $950,262
-10,241 Reduced 19.54%
42,171 $0
Q1 2019

May 08, 2019
BUY
$72.76 - $93.45 $966,762 - $1.24 Million
13,287 Added 33.96%
52,412 $4.89 Million
Q4 2018

Feb 12, 2019
SELL
$62.67 - $88.33 $9,713 - $13,691
-155 Reduced 0.39%
39,125 $2.73 Million
Q3 2018

Nov 13, 2018
SELL
$87.52 - $122.67 $781,203 - $1.09 Million
-8,926 Reduced 18.52%
39,280 $3.44 Million
Q2 2018

Aug 10, 2018
BUY
$88.31 - $107.8 $148,802 - $181,643
1,685 Added 3.62%
48,206 $4.75 Million
Q1 2018

May 10, 2018
BUY
$115.92 - $148.54 $1.87 Million - $2.4 Million
16,159 Added 53.22%
46,521 $5.55 Million
Q4 2017

Feb 09, 2018
BUY
$114.49 - $139.98 $2.46 Million - $3 Million
21,458 Added 240.99%
30,362 $3.85 Million
Q3 2017

Nov 09, 2017
BUY
$72.53 - $118.27 $645,807 - $1.05 Million
8,904
8,904 $1.05 Million

Others Institutions Holding ALNY

# of Institutions
643
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email